Partial PTEN Deletion in Breast Cancer
Partial PTEN Deletion and Its Relation to Clinicopathological Characteristics in Breast Cancer Patients
1 other identifier
observational
40
0 countries
N/A
Brief Summary
- Detection of chromosome 10q23 deletion including PTEN locus in breast cancer patients.
- Correlation between PTEN deletion and clinicopathological characteristics in breast cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2021
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2021
CompletedStudy Start
First participant enrolled
November 1, 2021
CompletedFirst Posted
Study publicly available on registry
November 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedNovember 8, 2021
October 1, 2021
3.2 years
October 27, 2021
October 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Detection of chromosome 10q23 deletion including PTEN locus in breast cancer patients.
Correlation between PTEN deletion and clinicopathological characteristics in breast cancer patients.
baseline
Eligibility Criteria
All stages of female patients with breast cancer. Median age was 63 (range 20-100) years
You may qualify if:
- all stages of breast cancer in females.
You may not qualify if:
- breast cancer in males.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assiut Universitylead
- principle investigatorcollaborator
Related Publications (1)
Young PA, Kaiser II. Aminoacylation of Escherichia coli cysteine tRNA by selenocysteine. Arch Biochem Biophys. 1975 Dec;171(2):483-9. doi: 10.1016/0003-9861(75)90057-0. No abstract available.
PMID: 963BACKGROUND
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
October 27, 2021
First Posted
November 8, 2021
Study Start
November 1, 2021
Primary Completion
December 30, 2024
Study Completion
January 30, 2025
Last Updated
November 8, 2021
Record last verified: 2021-10